| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc. | Chief Scientific Officer | Common Stock | 0 | $0 | $0.2542 | 07 Oct 2025 | Direct |
| Carisma Therapeutics Inc. | Chief Scientific Officer | Stock Option (right to buy) | 0 | 07 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CARM | Carisma Therapeutics Inc. | 07 Oct 2025 | 3 | -$8,217 | 4 | Chief Scientific Officer | 08 Oct 2025, 16:16 |
| CARM | Carisma Therapeutics Inc. | 01 Oct 2025 | 3 | -$124,343 | 4 | Chief Scientific Officer | 03 Oct 2025, 17:25 |
| CARM | Carisma Therapeutics Inc. | 28 Jan 2025 | 1 | $0 | 4 | Chief Scientific Officer | 30 Jan 2025, 16:02 |
| CARM | Carisma Therapeutics Inc. | 17 Jun 2024 | 1 | $0 | 4 | Chief Scientific Officer | 18 Jun 2024, 19:06 |
| CARM | Carisma Therapeutics Inc. | 31 Jan 2024 | 1 | $0 | 4 | Chief Scientific Officer | 02 Feb 2024, 16:53 |
| CARM | Carisma Therapeutics Inc. | 06 Jun 2023 | 1 | $0 | 4 | Chief Scientific Officer | 08 Jun 2023, 18:15 |
| CARM | Carisma Therapeutics Inc. | 07 Mar 2023 | 4 | $0 | 4 | Chief Scientific Officer | 09 Mar 2023, 20:27 |
| CARM | Carisma Therapeutics Inc. | 07 Mar 2023 | 0 | $0 | 3 | Chief Scientific Officer | 09 Mar 2023, 20:14 |